The manufacturer of a breast cancer drug which has been deemed "too expensive" to be offered by the NHS has hit back at the decision.
Dr Jayson Dallas, general manager of Roche Products Limited, declared it "an incredible injustice."
Despite Roche offering a significant discount, we are once again disappointed that Nice has not shown any flexibility on access to Kadcyla.
Refusing patients access to this drug is an incredible injustice and tantamount to turning the clock back in cancer research and development. We plan to appeal this decision.
More top news
Police are trying to find the driver of the car following the incident in Kingfisher Close, Brownhills.
An unnamed man died at the scene, while a woman was pronounced dead after being taken to St George's Hospital, Tooting, south-west London.
Eastern areas will see a few showers coming in on the northeasterly breeze